Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
Sales | 0 | 34,424 | 2,968 | 11,244 | 388 |
Cost of Goods | 0 | 8,144 | 1,525 | 4,383 | 3,575 |
Gross Profit | 0 | 26,280 | 1,443 | 6,861 | -3,187 |
Operating Expenses | 34,063 | 38,596 | 38,499 | 37,210 | 29,357 |
Operating Income | -34,063 | -12,172 | -36,531 | -29,966 | -31,969 |
Other Income | -674 | 554 | 2 | 968 | 529 |
Pre-tax Income | -34,737 | -11,618 | -36,529 | -28,998 | -31,440 |
Net Income Continuous | -34,737 | -11,618 | -36,529 | -28,998 | -31,440 |
Net Income Discontinuous | 6,947 | N/A | N/A | N/A | N/A |
Net Income | $-27,790 | $-11,618 | $-36,529 | $-28,998 | $-31,440 |
EPS Basic Total Ops | -3.00 | -1.30 | -4.30 | -3.60 | -4.10 |
EPS Basic Continuous Ops | -3.80 | -1.28 | -4.32 | -3.58 | -4.09 |
EPS Basic Discontinuous Ops | 0.80 | N/A | N/A | N/A | N/A |
EPS Diluted Total Ops | -3.00 | -1.30 | -4.30 | -3.60 | -4.10 |
EPS Diluted Continuous Ops | -3.80 | -1.28 | -4.32 | -3.58 | -4.09 |
EPS Diluted Discontinuous Ops | 0.80 | N/A | N/A | N/A | N/A |
EBITDA(a) | $-30,524 | $-8,480 | $-32,900 | $-26,833 | $-29,979 |